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ABSTRACT: The pandemic numbers of the new coronavirus 
have surpassed the other members of the Coronaviridae family, 
accumulating until today, more than 24 million cases of the 
disease. The knowledge acquired by previous outbreaks suggests 
that pregnant women and their fetuses are more susceptible 
to poor prognosis. The purpose of this review is to verify the 
manifestations of the SARS-CoV-2 infection in pregnant women 
and the risk of vertical transmission. The review includes 
manuscripts that, together, presented data from 205 pregnant 
women and 76 neonates. Among the results, the symptoms 
presented by pregnant women were the same as non-pregnant 
patients. The same was true for laboratory alterations, such as 
lymphopenia and ground-glass opacity on computed tomography. 
In total, 163 cesarean sections were performed due to impaired 
respiratory function, with one death reported. Regarding the 
results of testing the new coronavirus in neonates, only one 
neonate met the diagnostic criteria for congenital infection by 
SARS-CoV-2. The other five neonates who were positive soon 
after birth were not correctly tested, and the risk of infection during 
delivery and in the first hours was not ruled out. Finally, studies 
are necessary to support the exact risk of vertical transmission, 
assessing the influence of maternal viral load and other data, such 
as gestational age with a possible greatest risk for SARS-CoV-2 
transmission.
Keywords: Pregnant; Neonates; Coronavirus; COVID-19.
RESUMO: Os números da pandemia do novo coronavírus 
(COVID-19) ultrapassaram os outros membros da família 
Coronaviridae acumulando até o presente, mais de 24 milhões 
de casos da doença. O conhecimento adquirido pelos surtos 
anteriores sugere que gestantes e seus fetos são mais suscetíveis 
a prognósticos indesejáveis. Dessa forma, a presente revisão 
sistemática tem como objetivo avaliar as principais manifestações 
da infecção pelo vírus SARS-CoV-2 em gestantes e a possibilidade 
de transmissão vertical. Para isso, incluiu manuscritos que, ao 
todo, apresentavam dados de 205 gestantes e 76 neonatos. Entre 
os resultados, foi evidenciado que os sintomas apresentados pelas 
gestantes eram os mesmos que pacientes não grávidas, assim 
como as alterações laboratoriais, como linfopenia e a opacidade 
em vidro-fosco na tomografia computadorizada. No total, foram 
realizadas 163 cesáreas com a indicação de estado respiratório 
comprometido, com óbito de apenas uma paciente. Em relação 
aos resultados dos testes do novo coronavírus em neonatos, 
apenas um neonato, com seu estudo publicado em julho de 2020, 
encaixou-se nos critérios diagnósticos de infecção congênita por 
SARS-CoV-2. Os outros 5 neonatos que se apresentaram positivo 
logo após o nascimento, não apresentavam os testes corretos e 
o risco de infecção durante o parto nas primeiras horas não foi 
descartado. Dessa forma, estudos são necessários para embasar 
o exato risco de transmissão vertical, avaliando a influência da 
carga viral materna e outros dados como a idade gestacional de 
maior risco para a transmissão.
Palavras-chave: Gestantes; Neonatos; Coronavírus; COVID-19. 
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INTRODUCTION 
Emerging and reemerging pathogens are constant challenges worldwide, causing concerns for 
public health. The new SARS-CoV-2 - which was first 
discovered in December 2019 from a series of pneumonia 
patients linked to an unknown cause in Wuhan (China) - 
has spread and devastated the world. Although most human 
infections caused by a virus from the Coronaviridae family 
present with mild symptoms, two beta-coronaviruses, 
including the Severe Acute Respiratory Syndrome 
Coronavirus (SARS-CoV) and the Middle East Respiratory 
Syndrome Coronavirus (MERS-CoV) infected around 
10,000 individuals over the past two decades1. However, the 
new coronavirus (COVID-19) is by far the largest outbreak, 
accumulating millions of confirmed cases2.
Regarding the epidemiology and clinical 
characteristics of COVID-19, studies associated the first 
cases to a seafood market in Wuhan. Initially, transmission 
was assumed to be from animals to humans. However, 
exponential increase has since been reported due to 
transmission via human interactions. The first symptoms 
are very similar to other viral infections, such as fever, 
cough, myalgia, fatigue, and diarrhea. However, high fever 
and shortness of breath are symptoms that may indicate a 
severe disease, requiring greater medical attention³.
The knowledge acquired by previous outbreaks of 
SARS-CoV and MERS-CoV suggests that pregnant women 
and their fetuses are particularly susceptible to undesirable 
prognoses, and some studies have proven that the chance 
of death can increase by up to 35%4. Physiological changes 
in the woman’s body during pregnancy predispose them to 
a state of vulnerability against viral infections and severe 
course of pneumonia, with subsequent increase in maternal 
and fetal mortality5. Thus, anatomical changes - such as 
increased chest diameter that decreases hypoxia tolerance 
and changes in the mediating cells of the inflammatory 
system - may be responsible for increasing vulnerability, 
allowing pathogens to enter cells. Considering that the fetus 
and future neonate have an immune system in formation 
and adaptation, attention is necessary as they are extremely 
susceptible to infections6.
Studies have demonstrated associations between 
maternal viral infections and negative fetal outcomes, 
such as preterm delivery, neurological and cardiovascular 
malformation, and even chorioamnionitis. Hence, pregnant 
women and their newborns should be carefully assessed as a 
potential risk group that requires special attention in relation 
to prevention, diagnosis, and management during the 
COVID-19 pandemic7. Moreover, according to the Centers 
for Disease Control and Prevention (CDC), information 
about the effects of COVID-19 in pregnancy is still limited. 
Therefore, the knowledge about symptoms severity and 
associated complications, such as the possible risk of 
intrauterine transmission must be clarified8. Consequently, 
this systematic literature review was conducted in order to 
demonstrate the clinical and laboratory manifestations of 
SARS-CoV-2 infection in pregnant women and to evaluate 
the possible risk of intrauterine vertical transmission.
  
METHODS
In this study, protocols for systematic reviews 
were adopted (i.e., Preferred Reporting Items for 
Systematic Reviews and Meta-Analyses; PRISMA)9. The 
search for articles was performed in PubMed, Embase 
and LILACS platforms on August 10, 2020. The string 
used while searching for articles contained relevant 
combinations of keywords obtained from the Medical 
subject heading (MeSH terms), namely: “COVID-19” 
OR “coronavirus” OR “SARS” AND “pregnancy” OR 
“pregnant” OR “neonate” OR “vertical” OR “placental” 
OR “breastfeeding” OR “intrauterine”.   
The abstracts were analyzed according to the 
following inclusion criteria: observational studies, case 
reports, or randomized clinical trials published in 2020 
in English or Portuguese; moreover, full text availability, 
studies reporting on pregnant women who had confirmed 
diagnosis of COVID-19 exclusively by the real-time 
reverse-transcription polymerase chain reaction (RT-PCR) 
of SARS-CoV-2 and their neonates (to assess a possible risk 
of vertical transmission) were part of the inclusion criteria. 
Duplicate entries, abstract-only texts, opinion articles and 
studies that did not present a confirmatory diagnosis of 
COVID-19 in both pregnant women and their newborns 
were excluded from this review. Incomplete studies and 
those not performed in humans were excluded. 
Figure 1 details the procedures for searching 
and selecting manuscripts according to PRISMA 
recommendations. Out of the 35 documents recovered, 
20 were deemed potentially relevant after reading the 
abstracts (18 from PubMed and 2 from Embase). Fifteen 
non-clinical studies were excluded, 2 were excluded 
because the target population was not covered, 2 were not 
available in full-texts and another 5 had to be excluded 
for not reporting confirmed diagnosis of COVID-19 in 
pregnant women. Next, considering the articles that met the 
inclusion and exclusion criteria (n=11)10-20, a manual search 
was performed in the references of the articles, which 
resulted in the inclusion of one document21, thus resulting 
in 12 studies included in this review. We sought to ensure 
the quality of the articles included through the choice of 
high-quality repositories of the medical literature (e.g., 
PubMed, Embase, and LILACS). Although no specific tool 
was used to analyze risks of bias, authors’ notes regarding 
limitations/biases presented in their studies were considered 
in each publication. 
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Figure 1. Flow diagram for selecting studies according to PRISMA guidelines 
RESULTS 
According to the search strategy adopted, 12 
studies in accordance with the inclusion/exclusion criteria 
were identified; out of them, 8 were observational or 
retrospective studies with fairly large samples11-14,16,17,19,20 
and 4 were case studies10,15,18,21. In addition, all investigations 
were published between February 6 and July 14, 2020, 
coming mostly from China (n=10), but also from France 
(n=1), Peru (n=1) and Iran (n=1). 
Maternal data are presented in Table 1. Data were 
organized according to the age of patients, gestational age, 
history of chronic diseases, reported symptoms, laboratory 
and tomographic alterations, type of delivery, reasons given 
for cesarean section, and maternal deaths. Table 2 contains 
data from the neonates tested for COVID-19, including the 
type of test performed, its results, and number of neonatal 
deaths.
Maternal results 
The present systematic review reports data from 
205 pregnant women with a confirmatory diagnosis of 
COVID-19 exclusively via RT-PCR. According to Table 
1, the age of the patients ranged from 23 to 41 years old, 
and the gestational age at the time of the diagnosis varied 
between 5 to 41 weeks, while most of them occurred in 
the third gestational trimester. Few studies addressed the 
health history, chronic diseases, and other comorbidities of 
the patients before the infection by the novel coronavirus, 
yet thalassemia13, gestational diabetes13,16, valve surgery13, 
history of placenta previa13, hypothyroidism17, polycystic 
ovary syndrome17, uterine sinechia17, diabetes mellitus10, 
and systemic arterial hypertension16 were reported in some 
investigations.
 Regarding the symptoms reported and identified 
by physical examination, fever was the most frequent 
(n=105; 51%), followed by cough (n=63; 30%), fatigue 
(n=22; 11%), dyspnea (n=15; 7%), sore throat (n=15; 
7%), myalgia (n=13; 6%), and diarrhea (n=10; 5%). Nasal 
congestion was present in only one patient and 27 were 
asymptomatic. Increased C-reactive protein (n=88; 43%), 
lymphopenia (n=85; 41%), altered AST/ALT transaminases 
(n=10; 5%), high D-dimer (n=8; 4%), and procalcitonin 
(n=5; 2%) were the most frequent laboratory findings. Only 
one patient presented with high ferritin values. In terms of 
radiological results, the most frequent finding was ground-
glass opacity, present in two of the four case studies15,18 
and in 93% (n=104) of pregnant women in the only 
quantitative study detailing this alteration16. COVID-19 
infection, compromised respiratory status, preeclampsia, 
fetal distress, and premature rupture of membranes were 
the reasons given for cesarean sections performed (n=163; 
79%). In addition, there were 20 vaginal deliveries and 
22 ongoing pregnancies. No neonatal death was reported, 
but a case of maternal death was documented in a single 
report18.
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Neonatal outcomes 
Among all neonates born from mothers with 
confirmed infection by the novel coronavirus, 76 were 
tested for the disease (Table 2). Samples were taken from 
the nasopharynx and oropharynx by nasal swab, and/
or amniotic fluid, umbilical cord, and breast milk. In all 
samples, the RT-PCR method was applied, which was 
negative in 70 neonates.
Table 2. Neonatal outcomes
Authors, year, and origin Newborns tested (n) Tests Positive for COVID-19 Neonatal deaths 
Alzamora et al., 2020  
Peru  1 Nasal swab 1 0
Chen et al., 2020  
China 6
Nasal swab, amniotic 
fluid, umbilical cord, 
and breast milk
0 0
Hu et al., 2020   
China 7 Nasal swab 1 0
Liu et al., 2020 
China Not reported Not reported Not reported Not reported
Liu et al., 2020 
China 19
Nasal swab, amniotic 
fluid, umbilical cord, 
and breast milk
0 0
Lu et al., 2020  
China 18 Nasal swab 0 0
Vivanti et al., 2020  
France 1
Nasal swab and 
amniotic fluid 1 0
Wang et al., 2020 
China 1
Nasal swab, amniotic 
fluid, umbilical cord, 
and breast milk
1 0
Yan et al., 2020 
China 10 Umbilical cord 0 0
Yu et al., 2020 
China 3 Nasal swab 1 0
Zamaniyan et al., 2020
Iran 1
Nasal swab and 
amniotic fluid 1 0
Zhu et al., 2020  
China 9 Nasal swab 0 0
Regarding the positive tests for the novel coronavirus, 
Yu et al.17 found 1 out of 3 neonates tested who showed a 
positive result in the nasal swab sample, but this test was 
performed 36 hours following delivery, after the onset of 
mild symptoms and shortness of breath; two weeks later, 
the neonate was discharged when obtained two consecutive 
negative tests. Alzamor et al.10 also reported a neonate with 
positive nasal swab test 16 hours after delivery, followed 
by another test repeated in 48 hours which also confirmed 
the infection, even though the patient was in isolation from 
the first hour, evolving with severe shortness of breath and 
need for ventilatory support. Hu et al.12 described another 
newborn with a positive swab sample, but without detailing 
further testing. Wang et al.15 documented a positive case 
from a nasal swab performed 36 hours postpartum, yet with 
negative samples when taken from amniotic fluid, umbilical 
cord, and breast milk.
The newborn described in the case report from 
Zamaniyan et al.18 had tested positive for COVID-19 
via amniotic fluid collected at the time of the cesarean 
section; however, authors did not collect blood samples 
from the newborn, solely obtaining a positive nasal swab 
test 24 hours after birth. It is worth mentioning that all the 
studies cited so far did not rule out the possibility of failure 
in isolating mothers and neonates, as well as infection 
during cesarean section. Moreover, these investigations 
consider potential failures in the sterilization of surgical 
instruments, the risk of infection via health care workers 
who had contact with the newborns, and the possibility of 
false-negative results.
Perhaps a highlight among these studies was 
reported by Vivanti et al.21 when describing a neonate with 
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positive molecular test results for SARS-CoV-2 obtained 
from the amniotic fluid before the rupture of the membrane. 
In addition, nasal swab, blood, and placenta samples were 
taken from the newborn shortly after birth, also confirming 
the presence of the new coronavirus. The authors stated 
that this would be the first documented case of vertical 
transmission SARS-CoV-2, and the study was published 
on July 14, 2020.
DISCUSSION
Epidemiological exposure, clinical history, 
laboratory results, computed tomography findings, 
and samples analyzed via RT-PCR are used to confirm 
COVID-19 diagnosis. Here, 205 pregnant women had 
a positive RT-PCR result for SARS-CoV-2, which was 
included as one of the inclusion criteria for this study. 
However, the fifth edition of the guide “New coronavirus 
pneumonia prevention and control program” stated that, 
in the most affected areas of China, suspected cases 
with consistent tomographic findings could be clinically 
diagnosed as COVID-19 because RT-PCR false-negative 
rates reach up to 30%22. In another study, published in 
August 2020, the sensitivity of findings from computed 
tomography compatible with the infection by the new 
coronavirus was greater than the sensitivity for RT-PCR 
testing (98% vs. 71% respectively)23.
Additionally, ground-glass opacity was reported in 
104 out of the 116 patients evaluated by Yan et al.16 (included 
in this review), similarly to what has been found in other 
studies that specifically addressed these manifestations. The 
report “Radiological findings from 81 patients with 
COVID-19 pneumonia in Wuhan, China” - published in 
Lancet Infectious Diseases - included 81 patients, with 93% 
presenting ground-glass opacity on radiological images, 
suggesting that this is not a characteristic seen exclusively 
in pregnant women24.
Results from other members of the coronavirus 
family in pregnant women, such as Severe Acute 
Respiratory Syndrome Coronavirus (SARS-CoV-1) and 
Middle East Respiratory Syndrome Coronavirus (MERS-
CoV) have been reported in studies published in 200425 and 
20194, respectively. Thus, the severity of these pathogens 
and their complications during pregnancy, such as the 
need for orotracheal intubation, admission to intensive 
care units, renal failure, and a maternal death rate of up to 
35% were known4. However, as presented in this review, 
the impact of the new coronavirus on pregnant patients 
seems to be lighter, with only two cases reporting the need 
for intensive care10,18 and one resulting in maternal death 
(patient admitted with an oxygen saturation of 75-85%, 
reaching 70% after cesarean section and unresponsive to 
therapies and resuscitations)18. These data emphasize the 
recommendations from an editorial stating that guidelines 
should be based on data acquired in the current pandemic 
and not solely on previous outbreaks because the clinical 
response, the epidemiology, and treatments may be 
different26.
Fever was the most reported symptom, followed 
by cough, fatigue, dyspnea, sore throat, myalgia, and 
diarrhea. Lymphopenia and increased CRP were among 
the most notable laboratory alterations. In general, these 
symptoms are similar to those found in adult patients 
affected by the new coronavirus, thus not suggestive of any 
risk group. This is supported by two relatively large studies: 
the first one, by Huang et al.27 and published in January 202, 
evaluating 41 patients; and the second one, by Wang et al.28 
with a sample of 138 patients. In both investigations, the 
symptoms mentioned above were among the most frequent 
and were characterized as clinical manifestations of SARS-
CoV-2 infection. However, although it has been evidenced 
that pregnancy does not affect the symptomatology of the 
disease, some complications may have increased risk due 
to pregnancy, such as sepsis, intravascular disseminated 
coagulation, and acute renal injury29.
Cesarean section was indicated for 163 women and 
20 underwent vaginal delivery. The causes for pursuing 
cesarean section included fetal distress, premature rupture 
of the membrane, failure in the natural delivery process, 
and severe preeclampsia; however, the most cited cause 
was a compromised respiratory state of the patient due 
to the new coronavirus. Although some studies had not 
reported the reason for cesarean sections, it is possible 
that this decision was made due to understandable anxiety 
about the potential consequences of a novel and unknown 
viral infection30. As COVID-19 does not seem to be an 
extremely severe maternal disease, decisions should be 
taken by a multidisciplinary team and must consider 
obstetric indications of each patient. However, it is still 
reasonable to assume that there is a lack of evidence that 
cesarean sections are fully protective, and that vaginal 
delivery is not fully contraindicated29.
An international classification for case definition 
of SARS-CoV-2 infection in pregnant women, fetuses 
and neonates has been recently published. According to 
the authors, a neonatal congenital infection is confirmed 
against samples of amniotic fluid containing the virus, 
collected before membrane rupture, or blood samples taken 
in the first hours of life31. Thus, the six cases of neonates 
who tested positive for the new coronavirus among the 76 
tested that were included in this review should be reviewed 
with caution.
The neonates described by Alzamor et al.10, Hu et 
al.12, Wang et al.15 and Yu et al.17could not be classified 
as confirmed cases of intrauterine vertical transmission 
according to the international classification as nasal swab 
samples were taken a few hours after delivery31. The 
case reported by Zamaniyan et al.18 presented a sample 
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of positive amniotic fluid, but this was collected during 
cesarean section, and as already presented in the results, 
the authors did not rule out flaws regarding isolation or 
other methods of infection.
The only study presented in this review that could 
be classified as vertical intrauterine transmission would be 
the one described by Vivanti et al.21. In this case report, the 
newborn was tested by samples taken from amniotic fluid 
before rupture of the membrane, nasal swab, blood samples, 
and histological analysis of the placenta. From all these 
tests, confirmatory results for the new coronavirus were 
obtained. Besides, according to the analysis and evidence 
of high levels of angiotensin-converting enzyme 2 receptors 
in the placenta, authors were able to conclude that the 
transmission is possible in the last weeks of pregnancy, but 
studies are still lacking to assess the risk of transmission in 
the first and second trimester of gestational age21.
It is worth mentioning that, despite this isolated 
confirmed case of intrauterine vertical transmission 
following the international classification published by 
Shah et al.31, more studies should be carried out with 
larger samples and comprising pregnant women in the 
first and second trimester of pregnancy. Moreover, detailed 
attention to the patient’s viral load, something that has 
been the subject of recent a publication that demonstrated 
a relationship between viral load and the possibility of 
transmission of pathogens from the mother to the child32.
CONCLUSION 
The recently published studies do not allow to fully 
clarify all the complications caused by the new coronavirus 
in pregnant women and their newborns. However, as 
reported by this article, there was no difference between 
the clinical and laboratory manifestations of SARS-CoV-2 
infection among pregnant women when compared to 
non-pregnant women. Findings so far seem favorable, but 
maternal and fetal risk should not be ruled out. In respect 
to the risk of vertical transmission, studies reported a still 
significant lack of evidence; on the other hand, the first case 
was reported following the recently published diagnostic 
standards, which could increase concerns exponentially. 
Until now, scholars have claimed the lack of information 
to prove it and, although it has been an isolated case so far, 
more studies are needed to support the exact risk of vertical 
transmission, assessing the influence of maternal viral load 
and other data, such as gestational ages with higher risk 
for transmission.
This study has some limitations. For instance, 
articles published in Chinese were not included, and only 
women with a confirmatory diagnosis of COVID-19 by 
RT-PCR were included. Moreover, most of the patients 
were diagnosed in the third gestational trimester, which 
impeded the understanding on the effects of the disease in 
the first months of pregnancy. In addition, many studies 
did not report essential data. Although a total of 205 
pregnant women had their data here reviewed, with the 
majority being from China, this sample is small and with 
a lower relevance when compared to the rapid spread of 
the pandemic, which makes even more difficult to draw 
any definitive conclusions about the course of the new 
coronavirus in the studied population.
Finally, it seems clear that the best strategy available 
so far is to prevent maternal infection and consequently 
reduce neonatal exposure to the virus. Patients should 
be monitored according to prenatal, intrapartum, and 
postpartum guidelines, always ensuring the individuality 
of each patient by a multidisciplinary team.
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